GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines
GSK already has a strong presence in respiratory disease and immunology, two of its core therapeutic areas. The pharmaceutical giant ...
Monday, March 10, 2025
Tag: 150M
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.